Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether apixaban prevents the development of blood
clots in the leg (deep vein thrombosis) and lung (pulmonary embolism), which sometimes occur
after knee replacement surgery, and to compare the efficacy of apixaban with that of
enoxaparin (Lovenox®) in the prevention of these clots. The safety of apixaban will also be
studied.